Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective-Reference-Cited by-同舟云学术

Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective

Published:2003-01 Issue:2 Volume:31 Page:99-103
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Bargetzi M J,Passweg J,Baertschi E,Schoenenberger A,Gwerder C,Tichelli A,Burger J,Mingrone W,Herrmann R,Gratwohl A,Wernli M

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1703787.pdf

Reference18 articles.

1. Barlogie B, Alexanian R, Dicke K et al. High dose chemoradiotherapy and autologous bone marrow trans-plantation for resistant multiple myeloma. Blood 1987; 70: 869–872.

2. Fermand J-P, Chevret S, Ravaud P et al. High-dose chemoradiotherapy and autologous stem cell transplantation in multiple myeloma: Results of a phase II trial involving 63 patients. Blood 1993; 82: 2005–2009.

3. Harousseau J, Attal M, Divine M et al. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French registry on autologous transplantation in multiple myeloma. Blood 1995; 85: 3077–3085.

4. Attal M, Harousseau J-L, Stoppa A-M et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. New Engl J Med 1996; 335: 91–97.

5. Deskin R, Barlogie B, Sawyer J et al. Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities. Blood 2000; 95: 4008–4010.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Daratumumab during Myeloma Induction Therapy Is Associated with Impaired Stem Cell Mobilization and Prolonged Post-Transplant Hematologic Recovery;Cancers;2024-05-13

2. Long‐term safety of the stem cell releasing compound plerixafor for peripheral stem cell collection in myeloma patients;Hematological Oncology;2022-08-06

3. A new protocol for improving efficiency of autologous peripheral blood stem cell collection in patients with high white blood cell counts;Journal of Clinical Apheresis;2020-04-18

4. A randomized evaluation of vinorelbine versus gemcitabine chemotherapy mobilization of stem cells in myeloma patients;Bone Marrow Transplantation;2020-03-25

5. Hematopoietic Progenitor Cell Mobilization for Autologous Stem Cell Transplantation in Multiple Myeloma in Contemporary Era;Clinical Lymphoma Myeloma and Leukemia;2019-04